Pang, R;
Advic-Belltheus, A;
Meehan, C;
Fullen, DJ;
Golay, X;
Robertson, NJ;
(2021)
Melatonin for neonatal encephalopathy: From bench to bedside.
International Journal of Molecular Sciences
, 22
(11)
, Article 5481. 10.3390/ijms22115481.
Preview |
Text
Golay_Melatonin for Neonatal Encephalopathy- From Bench to Bedside_VoR.pdf - Published Version Download (1MB) | Preview |
Abstract
Neonatal encephalopathy is a leading cause of morbidity and mortality worldwide. Alt-hough therapeutic hypothermia (HT) is now standard practice in most neonatal intensive care units in high resource settings, some infants still develop long-term adverse neurological sequelae. In low resource settings, HT may not be safe or efficacious. Therefore, additional neuroprotective interventions are urgently needed. Melatonin’s diverse neuroprotective properties include antioxidant, anti-inflammatory, and anti-apoptotic effects. Its strong safety profile and compelling preclinical data suggests that melatonin is a promising agent to improve the outcomes of infants with NE. Over the past decade, the safety and efficacy of melatonin to augment HT has been studied in the neonatal piglet model of perinatal asphyxia. From this model, we have observed that the neuroprotective effects of melatonin are time-critical and dose dependent. Therapeutic melatonin levels are likely to be 15–30 mg/L and for optimal effect, these need to be achieved within the first 2–3 h after birth. This review summarises the neuroprotective properties of melatonin, the key findings from the piglet and other animal studies to date, and the challenges we face to translate melatonin from bench to bedside.
| Type: | Article |
|---|---|
| Title: | Melatonin for neonatal encephalopathy: From bench to bedside |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.3390/ijms22115481 |
| Publisher version: | http://doi.org/10.3390/ijms22115481 |
| Language: | English |
| Additional information: | This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| Keywords: | neonatal encephalopathy; melatonin; neuroprotection; therapeutic hypothermia; hypoxia-ischaemia |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Brain Repair and Rehabilitation UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL EGA Institute for Womens Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL EGA Institute for Womens Health > Neonatology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10129306 |
Archive Staff Only
 |
View Item |
